DRUG-seq Provides Unbiased Biological Activity Readouts for Neuroscience Drug Discovery
Jingyao Li(Shanghai University), Robert J. Ihry(Genomics Institute of the Novartis Research Foundation), Jeremy L. Jenkins(National Laboratory of the Rockies), Tayfun Tumkaya, Robin Ge, Chian Yang, Gopi Shanker, Daniel Ho(Novartis (United States)), Caroline Gubser Keller(Novartis (Switzerland)), Marc Hild(Pathways Behavioral Services), Kathleen A. Worringer(Johns Hopkins University), Frederic Sigoillot(Novartis (China)), Alicia Lindeman, Leandra Mansur, Brian Kelly(Hunter Medical Research Institute), Xiaoling Ke, Martin Hénault, Steffen Renner(Novartis (Switzerland)), Gilberto Soler‐Llavina, Carsten Russ(Broad Institute), Marilisa Neri(Novartis (Switzerland))
Cited by 34
Related Papers
A Draft Sequence of the Neandertal Genome
|Science|2010|4.6k
Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing
|Nature Biotechnology|2009|1.5k
Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries
|Genome biology|2011|1.2k